Combination therapy with both BRAF inhibitor vemurafenib and MEK inhibitor cobimetinib achieves greater progression-free survival…
Month: September 2014
Science
Continue Reading
Nivolumab shows signs of superior response rate compared to standard chemotherapy in advanced melanoma
The monoclonal antibody nivolumab achieves superior response rates and a longer duration of response than…
Science
Continue Reading
Asking parents smart questions can help obese kids lose weight
Preventing childhood obesity may begin at home, but there’s plenty nurses can do to help…
Science
Continue Reading
Cells from placentas safe for patients with multiple sclerosis, study shows
Patients with Multiple Sclerosis (MS) were able to safely tolerate treatment with cells cultured from…
Science
Continue Reading
‘Cloaking’ device uses ordinary lenses to hide objects across range of angles
Inspired perhaps by Harry Potter’s invisibility cloak, scientists have recently developed several ways — some…
Security
Continue Reading
Summary of Shellshock-Related Stories and Materials
Our coverage on the Bash bug vulnerability (more popularly known as “Shellshock”) continues as we…
Security
Continue Reading
Summary of Shellshock-Related Stories and Materials
Our coverage on the Bash bug vulnerability (more popularly known as “Shellshockâ€) continues as we…
Security
Continue Reading
Shellshock Exploit Attempts Continue in China
It seems like the floodgates have truly opened for Shellshock-related attacks. We have reported on…
Security
Continue Reading
Shellshock Exploit Attempts Continue in China
It seems like the floodgates have truly opened for Shellshock-related attacks. We have reported on…
Security
Continue Reading
Shellshock Continues to Make Waves with Active IRC Bot
Given the severity of the Bash bug vulnerability, also known as Shellshock, it is no…